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Gene-environment interactions have the potential to shed light on biological processes leading to disease and to improve the accuracy of
epidemiological risk models. However, relatively few such interactions have yet been confirmed. In part this is because genetic markers
such as tag SNPs are usually studied, rather than the causal variants themselves. Previous work has shown that this leads to substantial
loss of power and increased sample size when gene and environment are independent. However, dependence between gene and envi-
ronment can arise in several ways including mediation, pleiotropy, and confounding, and several examples of gene-environment inter-
action under gene-environment dependence have recently been published. Here we show that under gene-environment dependence, a
statistical interaction can be present between a marker and environment even if there is no interaction between the causal variant and
the environment.We give simple conditions under which there is nomarker-environment interaction and note that they do not hold in
general when there is gene-environment dependence. Furthermore, the gene-environment dependence applies to the causal variant and
cannot be assessed from marker data. Gene-gene interactions are susceptible to the same problem if two causal variants are in linkage
disequilibrium. In addition to existing concerns about mechanistic interpretations, we suggest further caution in reporting interactions
for genetic markers.There is much interest in discovering interactions between
genetic and environmental risk factors for disease, because
such interactions can shed light on biological processes
leading to disease, identify subjects for whom risk factors
are most relevant, and improve the accuracy of epidemio-
logical risk models.1 Interaction is commonly understood
as the modification by one factor of the effect of the other
and is assessed statistically by testing for departure from
additivity, on an appropriate scale, of the effects of gene
and environment. Such a definition can be dependent
on modeling assumptions and might not correspond to
biological notions of interaction,2–4 but it is nevertheless
useful in general exploratory settings.
To date, relatively few gene-environment interactions
have been reported, in contrast with the large number of
marginal associations discovered through genome-wide
association studies (GWASs). One reason is that there
might be relatively few subjects for whom the joint effect
of gene and environment is high, so that very large sam-
ples are required to detect interactions. Another is that
measurement error in either gene or environment can
lead to substantial increases in required sample size.5
Thus, robust identification of a gene-environment interac-
tion is regarded as a noteworthy finding.
In most studies, genotypes are measured not for the var-
iants that directly affect disease but for markers in linkage
disequilibrium (LD) with the causal variants. This is espe-
cially true in GWASs and other large-scale discovery studies
that aim to map novel disease variants. This creates a
misclassification problem in that the true causal variants
have been measured with error. In contrast to common1Department of Non-communicable Disease Epidemiology, London School o
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The Americanmeasurement error models, a marker is not an unbiased
measurement of a causal variant (because the genotype fre-
quencies of the marker and causal variant may differ), and
the misclassification probabilities are unknown by design.
General methods to adjust for measurement error6 are not
applicable, and so we must accept possible bias in the esti-
mation of interaction effects.
Through simulations, Hein et al.7 showed that the inter-
action effect of a marker is biased toward the null, with a
corresponding increase in the sample size required for a
study based on a marker. Garcia-Closas et al.8 showed
analytically that measurement error in the environmental
exposure also biases the interaction effect toward the null.
Furthermore, Greenwood et al.9 showed that the interac-
tion effect is not biased bymeasurement error in additional
covariates included in the model. All of these studies
assumed that the genetic marker and environmental expo-
sure are independent in the source population or in the
controls. Gene-environment independence also underlies
the case-only design10 and extensions of it designed to
improve the power of interaction tests.11–14 This assump-
tion is often reasonable: for example, autosomal genotypes
tend to be independent of sex. However, the properties of
interaction tests have not been considered when gene and
environment are not independent. Here we demonstrate
that under gene-environment dependence, the interaction
effect of a marker can be nonzero even if there is no inter-
action between the causal variant and the environment.
We and others recently established an association with
breast cancer of the marker rs10235235, which maps
to the CYP3A locus.15 This marker, which was initiallyf Hygiene and Tropical Medicine, London WC1E 7HT, UK; 2Breakthrough
7 3RP, UK; 3Division of Breast Cancer Research, The Institute of Cancer
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Figure 1. Directed Acyclic Graph Showing Gene-Environment
Dependence by Mediation
Boxes are observed variables, circles are unobserved, and arrows
indicate directions of causal relationships. Abbreviations are as
follows: D, causal variant; M, marker genotype; X, environmental
exposure; Y, outcome such as disease; A, composite variable for
ancestry, which gives rise to correlation (LD) between D and M;
and G, composite variable for common causes of X and Y, which
may include additional genes. X mediates the effect of D on Y.
For example, a CYP3A variant (D) affects the risk of breast cancer
(Y) via its effect on age at menarche (X).
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Figure 2. Directed Acyclic Graph Showing Gene-Environment
Dependence by Pleiotropy
Notation as in Figure 1. D has pleiotropic effects on X and Y, but
there is no direct effect of X on Y. For example, a CYP3A variant
(D) affects hormone levels, which independently affect age at
menarche (X) and breast cancer (Y). Age at menarche is an inde-
pendent risk factor for breast cancer because it marks additional
causal processes (G).identified through its association with urinary estrone
glucuronide,16 a metabolite that is correlated with the
sex hormone estradiol, is also associated with age at
menarche. We found a statistical interaction between
rs10235235 and age at menarche on breast cancer risk,
which is therefore a gene-environment interaction under
gene-environment dependence. However, rs10235235 is
not known to be the causal variant, and we will show
that the marker interaction does not imply an interaction
at the causal variant.
Also in breast cancer, Nickels et al.17 established a statis-
tical interaction between the marker rs3817198 at LSP1
(MIM 153432) with parity, but also reported significant
negative correlation between rs3817198 genotype and
number of births. Again, this is a gene-environment inter-
action in the presence of gene-environment dependence,
but rs3817198 is not known to be the causal variant.
As a further example, variants at chromosome 15q25
have been associated with both smoking and lung
cancer.18–20 Interactions between these variants and smok-
ing on lung cancer risk have also been identified,19,21 but
not for the likely causal variants.22
Gene-environment dependence could arise in a number
of ways. There is likely to be a genetic component to many
of the established risk factors for which interactions are
sought. In addition to the examples above, variants in
genes involved in alcohol metabolism have been associ-
ated with alcohol intake,23 which is a risk factor for
many diseases.24 GWASs have identified numerous vari-
ants associated with obesity, an established risk factor for
many complex disorders including type 2 diabetes and
breast cancer.25 Similarly, multiple variants that influence
low-density lipoprotein cholesterol levels, one of the stron-
gest risk factors for cardiovascular disease, have been iden-
tified.26 Even the more exogenous exposures, such as
urban environment, might conceivably have a genetic
component.27 However, on a per-gene basis, knowledge
of biological function could be invoked to argue that a
given gene is unlikely to affect an exposure of interest.
Figures 1, 2, and 3 illustrate three basic forms of gene-
environment dependence. Association of a gene with an302 The American Journal of Human Genetics 95, 301–307, Septembenvironmental risk factor is often taken to imply media-
tion of the genetic effect by the risk factor. That is, at
least part of the effect of the gene on the outcome is
via its effect on the environmental factor. For example,
a variant at the CYP3A locus might directly affect levels
of the hormone estradiol, which influences age at
menarche, which then directly affects breast cancer risk
(Figure 1).
On the other hand, the gene might have pleiotropic
effects on the environmental factor and the outcome,
but the environment might not cause the outcome. For
example, a CYP3A variant might, via estradiol levels, influ-
ence both age at menarche and breast cancer risk. Age at
menarche might have no direct effect on breast cancer,
so it does not mediate the effect of the CYP3A variant,
but it remains a risk factor by acting as a marker for other
mechanisms that affect disease (Figure 2).
Gene-environment dependence could also arise through
confounding, of which the principal source is population
structure. For example, some CYP3A haplotypes might
have become less frequent at northern latitudes. For unre-
lated reasons, age at menarche tends to be higher at
northern latitudes, leading to an association with CYP3A
variants (Figure 3). This confounding might be indepen-
dent of any confounding of the gene and outcome and
cannot be corrected using the standard methods to adjust
for gene-outcome confounding.
Any combination of the above three forms might occur
in practice, so for example a pleiotropic gene might affect
the outcome through several pathways, only one of
which is mediated by the environment of interest. The
corresponding graph would be a combination of Figures
1 and 2, including both direct and indirect effects of the
causal variant.
To formalize the interaction effects under gene-environ-
ment dependence, let M denote a genotyped marker,
coded numerically, X an environmental exposure, and Y
an outcome of interest. Consider a generalized linear
model
EðY jM;XÞ ¼ h1ðb0 þ bMM þ bXXþ bMXMXÞ;
where h is a known link function. Writing hm,x ¼ b0 þ
bMm þ bXx þ bMXmx, the interaction term in this model iser 4, 2014
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Figure 3. Directed Acyclic Graph Showing Gene-Environment
Dependence by Confounding
Notation as in Figure 1, with U an unmeasured confounder. D and
X are associated by confounding. For example, haplotype fre-
quencies at CYP3A (A) vary by latitude (U), as does age at
menarche (X). In this graph, U is not a confounder of D and Y;
such confounders are omitted for simplicity.bMX ¼ h1;1  h0;1  h1;0 þ h0;0: (Equation 1)
Let D denote the unmeasured genotype of the causal
variant, with a corresponding generalized linear model in
D and X
EðY jD;XÞ ¼ h1b0 þ bDDþ bXXþ bDXDX;
where the asterisks denote effects in the model forD rather
than for M. If the marker has no effect on the outcome,
conditional on D, then
EðY jM;XÞ ¼P
d
EðY j d;XÞPrðd jM;XÞ
h1hm;x ¼
X
d
h1

b0 þ bDd þ bXxþ bDXdx

Prðd jm; xÞ :
(Equation 2)
The conditional distribution Pr(DjM,X) accounts for
both the LD between marker and causal variant and the
dependence between exposure and causal variant. Equa-
tions 1 and 2 allow the marker interaction term to be
nonzero even when the interaction term for the causal
variant is zero. Some conditions under which the marker
interaction term is in fact zero are given in the following
lemma.
Lemma
If bDX ¼ 0, then bMX ¼ 0 if any of the following condi-
tions hold
(1) there is no main effect of the causal variant on the
outcome, bD ¼ 0
(2) the marker is perfectly correlated with the causal
variant, D ¼ M
(3) the causal variant is independent of the marker,
conditional on the exposure, Pr(DjM,X) ¼ Pr(DjX)
Furthermore, under linear (h(x)¼ x) or log-linear (h(x)¼
log(x)) regression, bMX ¼ 0 if
(4) the causal variant is independent of the exposure,
conditional on the marker, Pr(DjM,X) ¼ Pr(DjM)
Proof
If bDX ¼ 0 then the terms in bMX are explicitly
h1ðh1;1Þ ¼
P
d
h1ðb0 þ bDd þ bXÞPrðdjM ¼ 1;X ¼ 1ÞThe Americanh1ðh1;0Þ ¼
P
d
h1ðb0 þ bDdÞPrðdjM ¼ 1;X ¼ 0Þ
h1ðh0;1Þ ¼
P
d
h1ðb0 þ bDd þ bXÞPrðdjM ¼ 0;X ¼ 1Þ
h1ðh0;0Þ ¼
P
d
h1ðb0 þ bDdÞPrðdjM ¼ 0;X ¼ 0Þ
If bD ¼ 0 then
h1ðh1;1Þ¼
P
d
h1ðb0 þ bXÞPrðdjM ¼ 1;X ¼ 1Þ
¼ h1ðb0 þ bXÞ
h1;1 ¼ b0 þ bX
Similarly, h0;1 ¼ b0 þ bX and h1;0 ¼ h0;0 ¼ b0, so bMX ¼ 0
proving (1).
If marker and causal variant are perfectly correlated,
then trivially bMX ¼ bDX ¼ 0, which proves (2).
If Pr(DjM,X) ¼ Pr(DjX), then h1,1 ¼ h0,1 and h1,0 ¼ h0,0,
which proves (3).
Finally, if Pr(DjM,X) ¼ Pr(DjM) and either h(x) ¼ x or
h(x) ¼ log(x), then
h1;1 ¼ b0 þ bX þ
X
d
h1ðbDdÞPrðdjM ¼ 1Þ
h1;0 ¼ b0 þ
X
d
h1ðbDdÞPrðdjM ¼ 1Þ
h1;1  h1;0 ¼ bX
Similarly, h0;1  h0;0 ¼ bX under either link function, so
bMX ¼ 0 as required, which proves (4). Q.E.D.
Conditions (1)–(3) are reassuring because theymean that
whenamarker-exposure interactionexists, themarkermust
be associated with a causal variant. Furthermore, if the
causal variant is independent of the exposure, then (4)
shows that a marker-exposure interaction implies a causal
variant-exposure interaction, at least under linear or log-
linear regression (notably, this does not apply to logistic
regression, although for rare outcomes bMX will approach
0). However, if there is dependence between the causal
variant and the exposure, then a marker-exposure interac-
tion does not imply a causal variant-exposure interaction.
Therefore, tests ofmarker-exposure interaction arenot valid
tests of interaction between causal variant and exposure.
We illustrate this with a numerical example. Consider a
biallelic marker with population minor allele frequency
(MAF) 0.1. The risk allele of the causal variant is present
on half the chromosomes with the minor marker allele,
but on no other chromosomes. So the MAF of the causal
variant is 0.05, and the two loci are in linkage disequilib-
rium (D’ ¼ 1, r2 ¼ 0.47). If the risk allele has risk ratio 2,
then assuming multiplicative risks and Hardy-Weinberg
equilibrium, some simple calculations give the risk ratio
for the marker as 1.5 (Table 1 and Appendix A).
Now consider a binary environmental exposure such
that the risk ratio for the causal variant on the exposure
is 1.5. No main effect of the exposure is assumed, although
this does not matter in this example. Assuming that the
quantities in Table 1 apply to unexposed subjects, some
further calculations give the risk ratio for the marker as
1.6 in the exposed and 1.5 in the unexposed subjects
(Table 2 and Appendix A). This reveals an interaction be-
tween the marker and the exposure on the risk of disease,Journal of Human Genetics 95, 301–307, September 4, 2014 303
Table 1. Example Haplotype Frequencies for Disease and Marker Loci and Calculation of the Risk Ratio of the Marker
Frequency D ¼ 0 D ¼ 1 Total Pr(Y ¼ 1,D,M) D ¼ 0 D ¼ 1 Total RR(M)
M ¼ 0 0.9 0 0.9 0.9 0 0.9 1.0
M ¼ 1 0.05 0.05 0.1 0.05 0.1 0.15 1.5
Abbreviations are as follows: D, allele at causal variant; M, allele at marker locus; Y, disease phenotype. Risk ratio (RR) of D ¼ 1 is 2. Pr(Y ¼ 1,D,M) is relative to a
baseline that cancels in the marker risk ratio; see Appendix A for details of calculations.although there is none for the causal variant. We regard
this interaction as spurious, because it does not correspond
to an interaction at the causal variant.
The spurious interaction arises from imperfect LD
between the marker and causal variant, causing a
misclassification error that differs between cases and
controls, owing to the main effect of the causal variant,
but that also differs between exposed and unexposed
subjects, owing to the causal variant-exposure associa-
tion. It is important to note that the spurious interac-
tion cannot be removed by transformation of variables,
as can be done in other cases,4 but is a direct result
of measurement error of the causal variant. It does
not depend on the mechanism of gene-environment
dependence, of which Figures 1, 2, and 3 show a few
examples, but arises from simple algebra of the statistical
model.
A particular difficulty is that the bias depends on the
causal variant-exposure association, which cannot be
assessed from the marker data. Indeed, the marker
might not show association with the exposure, even if
the causal variant is associated with both. Even if the
marker is associated with the exposure, it is unclear
whether or not the causal variant would be independent
of the exposure after conditioning on the marker, as
required by the lemma. Therefore, any test of marker-
environment interaction is potentially suspect because it
cannot be determined from the data whether the causal
variant is associated with the exposure, conditional on
the marker.
Across the thousands of markers included in GWASs and
targeted array studies, it is likely that some will be in LD
with causal variants that are associated with the exposure
of interest. The fact that few gene-environment interac-
tions have been reported suggests that the magnitude of
the bias is small. Indeed, under a typical scenario for cur-
rent GWASs in which marker and causal variant have the
same MAF of 0.2, their correlation is r2 ¼ 0.8, and the
causal variant has odds ratio 1.1 with both disease and a
binary exposure, then similar calculations to those in
Table 2 give the interaction odds ratio for the marker
as 1.000433. More than a million cases and controls
would be needed to detect this effect with 80% power at
p < 0.05.28
However, higher interaction odds ratios can arise if the
causal variant and marker have differing MAF. As an
example, the marker rs10235235 observed at the CYP3A
locus15 has MAF 0.09 in women of European ancestry304 The American Journal of Human Genetics 95, 301–307, Septemband odds ratios for breast cancer of 0.979 (95% CI:
0.915–1.047) and 0.906 (95% CI: 0.864–0.950) in women
with age at menarche %12 years and >12 years, respec-
tively. This gives an interaction odds ratio of 1.08 (95%
CI: 0.990–1.176) (the original study used a finer categoriza-
tion of age at menarche, leading to a significant interac-
tion). Assume that the marker and causal variant have
the maximum correlation given their MAFs (i.e., D’ ¼ 1).
Treating the odds ratios as risk ratios, we can use the
approach shown in Table 2 to solve for the causal risk ratios
on disease and on exposure that lead to the observed
marker risk ratios, given a fixed causal MAF. For causal
MAF of 0.05, the observed marker effects can arise from
causal risk ratio 0.831 on disease and 0.116 on expo-
sure. This seems unlikely because such a strong effect
(0.116 ¼ 1 / 8.62) would probably be detected by a linkage
study, but this region was not identified in the largest link-
age scan for age at menarche.29 Similarly, a causal MAF of
0.01 implies a causal risk ratio of 0.155 (¼ 1 / 6.45) on dis-
ease and 0.208 on exposure, which again seems strong
considering the lack of evidence of linkage to breast cancer
in this region. However, a causal MAF of 0.02 implies
causal risk ratios of 0.577 (¼ 1 / 1.73) on disease and
0.187 (¼ 1 / 5.36) on exposure, which is more plausible.
Therefore, our observed marker interaction is compatible
with a low-frequency causal variant with strong main
effects but no interactions. Although common SNPs are
generally expected to tag common causal variants,30 the
possibility of a low-frequency causal variant suggests
caution in claiming a gene-environment interaction in
this case.
We have focused on gene-environment interaction, but
gene-gene interaction is likewise of high interest and
is also susceptible to this problem. There, a spurious inter-
action arises if two causal variants are in LD and at least
one is measured with error, such as by a marker SNP.
Recently, Hemani et al.31 have reported numerous cis
interactions between marker SNPs on gene expression
levels. However, many of the interactions can be ex-
plained by single variants in LD with both of the interact-
ing markers (A.R. Wood, personal communication). In
those cases the two causal variants are one and the
same: of course a single variant is in LD, but cannot
interact, with itself.
Measurement error can arise not only from a marker
in LD, but also from the numerical coding of the geno-
type. If, for example, the true effect of a causal variant
is dominant, but it is coded as additive and the linearer 4, 2014
Table 2. Example Haplotype Frequencies and Calculation of the Marker Risk Ratio in Unexposed and Exposed Subjects
Pr(D,MjX ¼ 0) D ¼ 0 D ¼ 1 Total Pr(Y ¼ 1,D,MjX ¼ 0) D ¼ 0 D ¼ 1 Total RR(MjX ¼ 0)
Unexposed
M ¼ 0 0.9 0 0.9 0.9 0 0.9 0.9/0.9 ¼ 1
M ¼ 1 0.05 0.05 0.1 0.05 0.1 0.15 0.15/0.1 ¼ 1.5
Exposed
M ¼ 0 0.9 0 0.9 0.9 0 0.9 0.9/0.9 ¼ 1
M ¼ 1 0.05 0.075 0.125 0.05 0.15 0.2 0.2/0.125 ¼ 1.6
Abbreviations are as follows: D, allele at causal variant; M, allele at marker locus. Risk ratio (RR) of D¼ 1 is 2 on disease Y and 1.5 on exposure X. Pr(Y¼ 1,D,MjX) are
relative to baselines that cancel in the marker risk ratio; see Appendix A for details of calculations.model is otherwise correct, then the miscoding could also
lead to a spurious interaction term. Furthermore, use of
imputed rather than directly measured genotypes also cre-
ates measurement error, particularly for causal variants
with strong effects because imputation is usually per-
formed assuming no association with the outcome.
Finally, exchanging the roles of gene and environment re-
veals that measurement error in the exposure could also
create a spurious interaction even if the genotype is accu-
rately measured.
The spurious interactions we have described are not
a serious problem when the aim is to construct epide-
miological models of risk, perhaps for disease predic-
tion, in which case model fit may be improved by
interaction terms. The real difficulty is with inference
of biological interaction from statistical models, andPrðY ¼ 1 jM ¼ 1;X ¼ 0Þ
PrðY ¼ 1 jM ¼ 0;X ¼ 0Þ ¼
X
d
RdPrðd;M ¼ 1 jX ¼ 0Þ
X
d
Prðd;M ¼ 0 jX ¼ 0Þ
X
d
RdPrðd;M ¼ 0 jX ¼ 0Þ
X
d
Prðd;M ¼ 1 jX ¼ 0Þ:our observations add to established concerns over the
interpretation of statistical interactions that are model
dependent.3 We believe that additional caution is
required in the interpretation of gene-environment inter-
actions, to allow for the possibilities of gene-environment
dependence and imperfect LD between marker and causal
variant. We suggest that sensitivity analyses such as
that described above ought to be routinely performed
to reduce the possibility of false positive reports of
interaction.Appendix A
Marker Risk Ratio in Unexposed
The frequency of haplotype D,M in unexposed subjects is
Pr(D,MjX ¼ 0). The joint probability of an affected subject
and haplotype D,M isThe AmericanPrðY ¼ 1;D;M jX ¼ 0Þ ¼PrðY ¼ 1 jD;M;X ¼ 0Þ
3PrðD;M jX ¼ 0Þ
¼ RDPrðY ¼ 1 jD ¼ 0;M;X ¼ 0Þ
3PrðD;M jX ¼ 0Þ
where RD is the causal variant risk ratio. The risk of disease
in an unexposed subject with marker M is
PrðY ¼ 1 jM;X ¼ 0Þ ¼PrðY ¼ 1;M jX ¼ 0ÞPrðM jX ¼ 0Þ
¼
X
d
PrðY ¼ 1;D ¼ d;M jX ¼ 0Þ

X
d
PrðD ¼ d;M jX ¼ 0Þ:
The risk ratio for the marker is thenMarker Risk Ratio in Exposed
Note that
PrðY ¼ 1;D;M jX ¼ 1Þ ¼ PrðY ¼ 1;X ¼ 1 jD;MÞ
3PrðD;MÞ=PrðX ¼ 1Þ
¼ SDPrðY ¼ 1;X ¼ 0 jD;MÞ
3PrðD;MÞ=PrðX ¼ 1Þ
¼ SDPrðY ¼ 1;D;M jX ¼ 0Þ
3PrðX ¼ 0Þ=PrðX ¼ 1Þ
where SD is the risk ratio of D on the exposure X.
Also
PrðD;M jX ¼ 1Þ ¼ PrðX ¼ 1 jD;MÞPrðD;MÞ=PrðX ¼ 1Þ
¼ SDPrðX ¼ 0 jD;MÞPrðD;MÞ=PrðX ¼ 1Þ
¼ SDPrðD;M jX ¼ 0ÞPrðX ¼ 0Þ=PrðX ¼ 1Þ
So the marker risk ratio in the exposed isJournal of Human Genetics 95, 301–307, September 4, 2014 305
PrðY ¼ 1 jM ¼ 1;X ¼ 1Þ
PrðY ¼ 1 jM ¼ 0;X ¼ 1Þ ¼
X
d
SdRdPrðd;M ¼ 1 jX ¼ 0Þ
X
d
SdPrðd;M ¼ 0 jX ¼ 0Þ
X
d
SdRdPrðd;M ¼ 0 jX ¼ 0Þ
X
d
SdPrðd;M ¼ 1 jX ¼ 0ÞThe above calculations may be performed using Table S1
available online.Supplemental Data
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